XSNX >>OVERSOLD NITRUZZZ NEWSLETTER RELEASED //Adds to Technology & Business Capabilities
Date: 05/13/2013
Good Morning,
The last month was very busy here at XsunX. In addition to our continued work with our CIGSolar® technology and sales efforts, we ramped up our efforts to add to our technology and business development resources.
One of our projects was helping a customer prepare the financial presentations for an expansive business plan, focusing on capitalizing on near-term opportunities in the Caribbean region.
With costs for delivered electricity in the Caribbean hovering at $0.37 a kWh, our customer's plan addresses the government's interest of diversifying job markets, increasing employment, and thereby raising the standard of living. This is a great opportunity both for our client and for the people in the Caribbean and we are excited to be part of these plans.
For more on this, last Friday Mr. Tom Djokovich, in an interview on MoneyTV, provided additional insight to the Company's efforts with customers. You can view the interview here.
Strengthening Our CIGS Technological and Business Capabilities
With the transition from build-out to start-up, calibration and marketing of our CIGSolar® technology, we have also been looking to strengthen our technology and business development capabilities through the addition of seasoned industry veterans.
We are pleased to announce the addition of Dr. John Tuttle to our scientific and business development staff. Dr. Tuttle is joining as Senior Scientific and Business Advisor and brings over 25 years of thin film and CIGS technology, systems, and business development success to XsunX. His extensive background includes 10+ years with the National Renewable Energy Laboratories (NREL) where, as a senior scientist, his R&D efforts led to multiple patent awards and CIGS PV devise records. Dr. Tuttle's entrepreneurial efforts and comprehensive knowledge of the Cleantech industry are equally extensive.
There will be more to come on Dr. Tuttle's remarkable background in the near future, but we wanted to include a brief update of the good news in this week's newsletter for our valued shareholders.
As always, we are working hard to capitalize the full potential of CIGSolar® for our shareholders and look forward to sharing more progress with you in the near future.
Thanks for your time.
Tom Djokovich, CEO
To learn more about XsunX's' breakthrough technology please visit http://www.xsunx.com.
Safe Harbor Statement: Matters discussed in this shareholder newsletter contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this shareholder newsletter, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.
Posted On: 05/13/2013 9:36:57 AM
Post# of 25193
(0)
(0)
Top 10 Most Recent Blog Posts
Tilray Brands, Inc. (TLRY): A Global Cannabis Leader
Category: Stocks Total Views: 98
By : Kelly Martin Updated: 07-29-2024
Overview of Tilray Brands, Inc.
Tilray Brands, Inc. (NASDAQ: TLRY) is a pioneering company in the field of medical and recreational cannabis production and research. Headquartered in Canada, Tilray has positioned itself as a global leader with a commitment to providing safe, consistent, and reliable therapy to patients and consumers worldwide. The company operates in multiple regions, including Canada, the United States, Europe, Australia, and Latin America, serving a diverse clientele rangin... Continue Reading
Understanding the Demand Generation Process for Business Growth
Category: Business Total Views: 111
By : Ryan Hughes Updated: 07-29-2024
Introduction to Demand Generation
In the fast-paced world of digital marketing and advertising, understanding the demand generation process is crucial for business growth. Demand generation is a comprehensive strategy aimed at creating awareness and interest in a company's products or services, ultimately driving customer engagement and revenue. For advertisers, especially in the realm of connected TV advertising, mastering demand generation can significantly enhance performance marketing... Continue Reading
Philips Unveils New AI Cardiovascular Ultrasound Platform
Category: Stocks Total Views: 106
By : Henry Turner Updated: 07-29-2024
Philips Reports Strong Order Intake Growth in Q2 2024
With a 9% rise over past periods, Philips's order intake in Q2 2024 rose significantly. Mostly, the North American market drove this expansion. With group sales of EUR 4.5 billion, the company said that comparable sales had risen by 2%. Operations brought in EUR 816 million, of which EUR 538 million came from insurance earnings. The changed EBITA margin climbed to 11.1% of sales. Apart from a free cash outflow of EUR 64 million, Philip... Continue Reading
High-Purity Canola Protein: Burcon’s New Achievement
Category: Stocks Total Views: 146
By : Dominic Sanders Updated: 07-29-2024
Burcon NutraScience Achieves Milestone in Canola Protein Production
Leader in plant-based protein technologies, Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) has effectively finished its first end-to-end validation trial for manufacturing high-purity canola protein isolate. For Burcon's goal of releasing creative, plant-based protein solutions onto the market, this success represents a major forward step.
Commercialization of Canola Protein Technology
Burcon's commerc... Continue Reading
Cosa's Orbit Project Gains Untapped Exploration Areas
Category: Stocks Total Views: 150
By : Caleb Price Updated: 07-29-2024
Acquisition of Mineral Claims in Athabasca Basin
Skyharbour Resources LTD. has signed an asset purchase agreement with Cosa Resources Corp. Signed July 26, 2024, the agreement calls for acquiring two mineral claims in the Athabasca Basin, Saskatchewan. With 12,718 hectares, these claims will double the footprint of the Orbit uranium project. With this purchase, Cosa will be able to increase its eight kilometer control of untested strike length. The claims follow trend with uranium mineralizat... Continue Reading
Hyperfast Title Joins reAlpha's AI Homebuying Platform
Category: Stocks Total Views: 176
By : Riley Hayes Updated: 07-29-2024
reAlpha Acquires 85% Stake in Hyperfast Title, LLC
85% of Hyperfast Title, LLC. has been acquired by reAlpha Tech Corp. Hyperfast calls Florida, Virginia, and Tennessee home. This purchase expands the portfolio of reAlpha with title and settlement services. Re Alpha is renowned for creating real estate artificial intelligence technologies. The purchase from Madison Settlement Services fits the expansion plan of reAlpha. This action enhances the homebuying market offerings from reAlpha. The in... Continue Reading
Long-term Projections for AI Technologies Development
Category: Business Total Views: 148
By : Hannah Lewis Updated: 07-29-2024
The Rise of Generative AI: Transforming Industries and Investment Strategies
By allowing the creation of fresh content—text and images as well as music and design—generative artificial intelligence is changing sectors. Companies use this technology to improve operations and boost inventiveness. Generative artificial intelligence creates tailored marketing materials in advertising, so boosting interaction. In the medical field, it helps with new medical imaging creation and drug di... Continue Reading
New Alzheimer's Treatment: Anavex's Blarcamesine Success
Category: Stocks Total Views: 211
By : Addison Perry Updated: 07-29-2024
Anavex Life Sciences Reports Promising Results for Alzheimer's Treatment
From its Phase IIb/III study on blarcamesine (ANAVEX®2-73), a medication for early Alzheimer's disease (AD), Anavex Life Sciences Corp. (Nasdaq: AVXL) has reported encouraging findings. Leading neurology specialist Dr. Marwan Noel Sabbagh delivered the data at the 2024 Alzheimer's Association International Conference (AAIC). Taken once daily, blarcamesine has shown great promise in halting the advance of ... Continue Reading
Windtree's Latest Advances: Istaroxime Clinical Trials
Category: Stocks Total Views: 273
By : Lucas Young Updated: 07-28-2024
Windtree Therapeutics Updates Istaroxime Clinical Development and Trial Data
Providing a thorough update on the clinical and business development of istaroxime, Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company committed to developing creative therapies for critical diseases, has This first-in-class treatment seeks to raise blood pressure, preserve or increase renal function, and strengthen systolic contraction and diastolic relaxation of the heart. In three Phase 2 trials... Continue Reading
SEC Charges Citron Capital in Multi-Year Fraud Scheme
Category: Investing Total Views: 257
By : Evelyn Baker Updated: 07-28-2024
SEC Charges Andrew Left and Citron Capital in $20 Million Fraud Scheme
Andrew Left and his company, Citron Capital LLC, have been charged with a $20 million fraud by the Securities and Exchange Commission (SEC). They are activists short sellers. The SEC complaint claims Left recommended stock positions using his Citron Research website and social media platform. He said these positions complemented Citron Capital's and his own investments. Left's recommendations, according to the SEC,... Continue Reading